Results per Page:
Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
Surviving and thriving with metastatic breast cancer
From financial toxicity to sexual health, experts break down survival strategies for patients and caregivers dealing with ‘mets’
Fred Hutch and UW hematology/oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
How do we increase equity in cancer care?
HICOR’s Value in Cancer Care Summit brings together stakeholders to discuss barriers, pain points and solutions
First Lady Jill Biden: ‘Your work will change and save lives’
MET-X research lab tour and Cancer Moonshot ‘listening session’ on survivorship and pediatric cancer highlight First Lady's visit to Fred Hutch
Cancer chemo side effects and how to limit them
A Q & A with physician-scientist Dr. Gary Lyman on his new Nature review of acute chemotherapy-associated adverse events
New studies highlight cancer inequities in hospice care, financial impacts
Analyses shared at ASCO annual meeting show lack of home hospice care for Medicaid patients during COVID-19; quantify financial hardships
New study: Financial hardship common with metastatic colorectal cancer
Despite health insurance, almost three-fourths of these patients experienced financial hardship within first year after diagnosis
New cancer drugs lead to life-threatening financial choices
Hutch researchers in HICOR take on one of cancer treatment’s deadliest side effects, financial toxicity; call for Medicare policy change
How to achieve equity in cancer care, research and beyond
New national reports outline our progress on cancer and issue a call to action to eliminate structural racism that drives health disparities
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Dr. Veena Shankaran named 2019 Leader in Health Care
Seattle Business magazine honors oncologist, health services researcher
Biologics and biosimilars step onto the cancer therapy stage
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?